Ticker Details
Allogene Therapeutics, Inc.
IPO Date:	October 8, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$460.7M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.43 | 3.17%
Avg Daily Range (30 D):	$0.09 | 5.06%
Avg Daily Range (90 D):	$0.06 | 4.00%

Institutional Daily Volume
Avg Daily Volume:	1.67M
Avg Daily Volume (30 D):	6M
Avg Daily Volume (90 D):	3.66M

Trade Size
Avg Trade Size (Sh.):	155
Avg Trade Size (Sh.) (30 D):	403
Avg Trade Size (Sh.) (90 D):	364

Institutional Trades
Total Institutional Trades:	2,918
Avg Institutional Trade:	$1.85M
Avg Institutional Trade (30 D):	$1.05M
Avg Institutional Trade (90 D):	$1.02M
Avg Institutional Trade Volume:	.18M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.44M
Avg Closing Trade (30 D):	$.98M
Avg Closing Trade (90 D):	$.99M
Avg Closing Volume:	234.74K

News

Dec 16, 2025 @ 6:09 PM Allogene Arbitration Victory Pressures Cellectis S... Source: Vandana Singh

Dec 15, 2025 @ 10:39 PM Allogene Therapeutics Reports Favorable Result for... Source: Allogene Therapeutics

Nov 27, 2025 @ 4:00 PM U.S. CAR T-Cell Therapies Market Grows at 30.4% CA... Source: Towards Healthcare

Jul 23, 2025 @ 1:26 PM High‑Growth Oncology Market Projected For U... Source: Prnewswire

Jun 1, 2025 @ 2:45 PM Allogene Therapeutics Provides Updated Phase 1 Dat... Source: N/A

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.19		$-.28
Diluted EPS	$-.19		$-.28
Revenue	$M		$M
Gross Profit
Net Income / Loss	$-41.4M	$-50.94M	$-59.73M
Operating Income / Loss	$-44.9M		$-65.19M
Cost of Revenue
Net Cash Flow			$-32.76M
PE Ratio